Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: Report from the JPLT

Pediatric Surgery International

Volumn 27, Issue 1, 2011, Pages 1-8

  Hishiki, Tomoro ^a   Matsunaga, Tadashi ^a   Sasaki, Fumiaki ^b   Yano, Michihiro ^c   Ida, Kohmei ^d   Horie, Hiroshi ^e   Kondo, Satoshi ^f   Watanabe, Ken Ichiro ^g   Oue, Takaharu ^h   Tajiri, Tatsuro ⁱ   Kamimatsuse, Arata ^j   Ohnuma, Naomi ^a   Hiyama, Eiso ^j  

^a CHIBA UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AKITA UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e CHIBA CHILDREN'S HOSPITAL   (Japan)

^f NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^g KYOTO UNIVERSITY   (Japan)

^h OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j HIROSHIMA UNIVERSITY   (Japan)

more..

Author keywords

Hepatoblastoma; PRETEXT; Prognostic factors; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; PIRARUBICIN;

ADOLESCENT; ARTICLE; BACTEREMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CHILD; CLINICAL PROTOCOL; DRUG FATALITY; DRUG MEGADOSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOBLASTOMA; HUMAN; INFANT; JAPANESE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; NEUTROPENIA; OTOTOXICITY; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATOBLASTOMA; HUMANS; IFOSFAMIDE; INFANT; INFANT, NEWBORN; JAPAN; LIVER; LIVER NEOPLASMS; MALE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 78751634654     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-010-2708-0     Document Type: Article

References (33)

1. JA Ortega EC Douglass JH Feusner, et al. 2000 Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group J Clin Oncol 18 2665 2675 1:CAS:528:DC%2BD3cXls12iurc%3D 10894865
2. J Fuchs J Rydzynski D von Shweinitz, et al. 2002 Pretreatment prognostic factors and treatment results in children with hepatoblastoma. A report from the German Cooperative Pediatric Liver Tumour Study HB94 Cancer 95 172 182 10.1002/cncr.10632 12115331 (Pubitemid 34743496)
3. G Perilongo E Shafford R Maibach, et al. 2004 Risk-adapted treatment for childhood hepatoblastoma: final report of the second study of the International Society of Paediatric Oncology - SIOPEL 2 Eur J Cancer 40 411 421 1:STN:280:DC%2BD2c%2Fks1WksQ%3D%3D 10.1016/j.ejca.2003.06.003 14746860 (Pubitemid 38121279)
4. F Sasaki T Matsunaga M Iwafuchi, et al. 2002 Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: a report from the Japanese Study Group for Pediatric Liver Tumor J Pediatr Surg 37 851 856 1:STN:280:DC%2BD383ps12hsg%3D%3D 10.1053/jpsu.2002.32886 12037748 (Pubitemid 34575792)
5. HM Katzenstein WB London EC Douglass, et al. 2002 Treatment of unresectable and metastatic hepatoblastoma: a Pediatric Oncology Group Phase II Study J Clin Oncol 20 3438 3444 10.1200/JCO.2002.07.400 12177104
6. T Matsunaga F Sasaki M Ohira, et al. 2003 Analysis of treatment outcome for children with recurrent or metastatic hepatoblastoma Pediatr Surg Int 19 142 146 12768314
7. MH Malogolowkin H Katzenstein MD Krailo, et al. 2006 Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma J Clin Oncol 24 2879 2884 1:CAS:528: DC%2BD28XntV2gs74%3D 10.1200/JCO.2005.02.6013 16782927 (Pubitemid 46630589)
8. P Czauderna JB Otte DC Aronson, et al. 2005 Guidelines for surgical treatment of hepatoblastoma in the modern era - recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL) Eur J Cancer 41 1031 1036 10.1016/j.ejca.2005.02.004 15862752 (Pubitemid 40602855)
9. EP Tagge DU Tagge J Reyes, et al. 1992 Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival J Pediatr Surg 27 292 297 1:STN:280:DyaK38zmsVOgsQ%3D%3D 10.1016/0022-3468(92)90849-3 1323649
10. DR King J Ortega J Campbell, et al. 1991 The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapy J Pediatr Surg 26 1074 1081 1:STN:280:DyaK38%2FksFaktQ%3D%3D 10.1016/0022-3468(91)90677-L 1658289
11. G Perilongo R Maibach E Shafford, et al. 2009 Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma N Engl J Med 361 1662 1670 1:CAS:528:DC%2BD1MXhtlSqtLbN 10.1056/NEJMoa0810613 19846851
12. J Brown G Perilongo E Shafford, et al. 2000 Pretreatment prognostic factors for children with hepatoblatoma - results from the International Society of Paediatric Oncology (SIOP) Study SIOPEL 1 Eur J Cancer 36 1418 1425 1:STN:280:DC%2BD3cvisVCisg%3D%3D 10.1016/S0959-8049(00)00074-5 10899656 (Pubitemid 30421147)
13. DC Aronson JM Schnater CR Staalman, et al. 2005 Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Grou p SIOPEL-1 study J Clin Oncol 23 1245 1252 10.1200/JCO.2005.07.145 15718322 (Pubitemid 46202282)
14. RL Meyers JR Rowland M Krailo, et al. 2009 Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group Pediatr Blood Cancer 53 1016 1022 10.1002/pbc.22088 19588519
15. E Koh Y Ueda T Nakamura A Kobayashi S Katsuta H Takahashi 2002 Apoptosis in young rats with adriamycin-induced cardiomyopathy - comparison with pirarubicin, a new anthracycline derivative Pediatr Res 51 256 259 1:CAS:528:DC%2BD38Xht1yktbk%3D 10.1203/00006450-200202000-00021 11809923
16. J Zsíros R Maibach E Shafford, et al. 2010 Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study J Clin Oncol 28 2584 2590 10.1200/JCO.2009.22.4857 20406943
17. JB Otte J Oritchars DC Aronson, et al. 2004 Liver transplantation for hepatoblastoma: results from the international society of pediatric oncology (SIOP) study SIOPEL-1 and review of the world experience Pediatr Blood Cancer 42 74 83 1:STN:280:DC%2BD2c%2FltFCnuw%3D%3D 10.1002/pbc.10376 14752798
18. JB Otte JV de Goyet R Reding 2005 Liver transplantation for hepatoblastoma: indications and contraindications in the modern era Pediatr Transplant 9 557 565 10.1111/j.1399-3046.2005.00354.x 16176410 (Pubitemid 41413492)
19. JD Reyes B Carr I Dvorchik, et al. 2000 Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence J Pediatr 136 795 804 1:STN:280:DC%2BD3c3pvFSiug%3D%3D 10.1067/mpd.2000.106223 10839879
20. K Tanaka S Uemoto Y Tokunaga, et al. 1993 Surgical techniques and innovations in living related liver transplantation Ann Surg 217 82 91 1:STN:280:DyaK3s7ktlCitw%3D%3D 10.1097/00000658-199301000-00014 8424706 (Pubitemid 23033223)
21. M Kasahara M Ueda H Haga, et al. 2005 Living-donor liver transplantation for hepatoblastoma Am J Transplant 5 2229 2235 10.1111/j.1600-6143.2005.01003.x 16095502 (Pubitemid 41648470)
22. S Nishimura T Sato N Fujita, et al. 2002 High-dose chemotherapy in children with metastatic hepatoblastoma Pediatr Int 44 300 305 1:CAS:528:DC%2BD38XlsVehsLk%3D 10.1046/j.1442-200X.2002.01549.x 11982901 (Pubitemid 34827731)
23. M Yoshinari M Imaizumi Y Hayashi, et al. 1998 Peripheral blood stem cell transplantation for hepatoblastoma with microscopical residue: a therapeutic approach for incompletely resected tumor Tohoku J Exp Med 184 247 254 1:STN:280:DyaK1c3ltlGltw%3D%3D 10.1620/tjem.184.247 9591340 (Pubitemid 28198652)
24. S Kitahara M Makuuchi S Ishizone, et al. 1995 Successful left trisegmentectomy for ruptured hepatoblastoma using intraoperative transarterial embolization J Pediatr Surg 30 1709 1712 1:STN:280:DyaK28zlslCjtg%3D%3D 10.1016/0022-3468(95)90460-3 8749932
25. T Iida M Senaga Y Takeuchi, et al. 2004 Successful resection of a ruptured hepatoblastoma prior to chemotherapy: report of a case Surg Today 34 710 714 10.1007/s00595-004-2766-9 15290405
26. J Hara Y Osugi H Ohta, et al. 1998 Double-conditioning regimens consisting of thiotepa, melphalan and busulfan with stem cell rescue for the treatment of pediatric tumors Bone Marrow Transplant 22 7 12 1:STN:280:DyaK1czktF2huw%3D%3D 10.1038/sj.bmt.1701283 9678789
27. S Suita T Tajiri H Takamatsu, et al. 2004 Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen - a report from the study group for pediatric solid malignant tumors in the Kyushu area J Pediatr Surg 39 195 198 1:STN:280:DC%2BD2c%2Fns1KmsQ%3D%3D 10.1016/j.jpedsurg.2003.10. 012 14966739 (Pubitemid 38146436)
28. D von Schweinitz H Hecker D Harmas, et al. 1995 Complete resection before development of drug resistance is essential for survival from advanced hepatoblastoma - a report from the German Cooperative Pediatric Liver Tumor Study HB-89 J Pediatr Surg 30 845 852 10.1016/0022-3468(95)90762-9
29. HM Katzenstein C Rigsby PH Shaw, et al. 2002 Novel therapeutic approaches in the treatment of children with hepatoblastoma J Pediatr Hematol Oncol 24 751 755 10.1097/00043426-200212000-00014 12468918 (Pubitemid 35448742)
30. RD Palmer DM Williams 2003 Dramatic response of multiply relapsed hepatoblastoma to irinotecan (CPT-11) Med Pediatr Oncol 41 78 80 10.1002/mpo.10300 12764754 (Pubitemid 41103263)
31. O Ijichi S Ishikawa Y Shinkoda, et al. 2006 Response of heavily treated and relapsed hepatoblastoma in the transplanted liver to single-agent therapy with irinotecan Pediatr Transplant 10 5 635 638 10.1111/j.1399-3046.2006.00517.x 16857004
32. LR Bomgaars M Bernstein M Krailo, et al. 2007 Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study J Clin Oncol 25 4622 4627 1:CAS:528:DC%2BD2sXht1yhsrzN 10.1200/JCO.2007.11.6103 17925558 (Pubitemid 350035322)
33. M Qayed C Powell ER Morgan, et al. 2010 Irinotecan as maintenance therapy in high-risk hepatoblastoma Pediatr Blood Cancer 54 761 763 20063426